Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy

Table 1 Clinicopathologic characteristics of 52 patients undergoing total pancreatectomy

Variable	No. of patients
Mean age ± SD (yr)	60.3 ± 9.0
Sex (male)	32
Pathology
Adenocarcinoma	43
Cystadenocarcinoma	2
Invasive IPMN	4
Acinar adenocarcinoma	1
Adenosquamous carcinoma	1
Renal cell carcinoma metastasis	1
Tumor location
Head	28
Corpus	15
Tail	3
> 1 location	6
Median primary tumor size (IQR) (cm)	4.7 (3.0-6.0)
Venous invasion	26
Lymph node invasion	18
Splenectomy	11
Operative time (IQR) (min)	472.5 (421.3-548.8)
Operative arrangement
Planned	20
Unplanned	32
Postoperative complication1
Gastroplegia	4
Gastrointestinal or abdominal hemorrhage bleeding	1
Pneumonia	14
Abdominal infection	9
Hepatic failure	1
Respiratory failure	1
Length of postoperative hospital stay (IQR) (d)	12.0 (10.0-17.8)
Neoadjuvant treatment	14
Adjuvant treatment	52
Median recurrence-free time (IQR) (mo)	4.7 (2.7-13.6)
Median survival time (IQR) (mo)	20.9 (10.2-51.0)
1-year survival (%)	63.4
3-year survival (%)	24.2
5-year survival (%)	12.5

¹Five patients had two complications simultaneously, and one patient had three complications simultaneously. IPMN: Intraductal papillary mucinous neoplasms.